Cardisio

Cardisio is a German digital cardiology and medical device company focused on early, non-invasive detection of heart disease. Its core product, Cardisiography, combines 5-lead 3D vectorcardiography, cloud computing, and AI/neural-network analysis to identify pathological cardiac patterns at rest and generate a risk-scored report within minutes. The company markets its solution for detection or rule-out of coronary and structural heart disease and also references arrhythmia and heart-failure-related screening use cases. Founded in 2016 and headquartered in Frankfurt am Main, Cardisio operates commercially through its own organization and distribution partners in multiple countries. The business is best characterized as a commercial-stage cardiovascular diagnostics platform rather than a therapeutics developer.